Skip to main content

Table 1 Comparison of healthcare exposure of reference cohort (A) and transient ischemic attack (TIA) study cohort before (B) and after (C) index hospitalization

From: Management, prognosis and predictors of unfavourable outcomes in patients newly hospitalized for transient ischemic attack: a real-world investigation from Italy

 

Reference cohort

TIA study cohort

p-value

One year before index hospitalization (A)

One year before index hospitalization (B)

One year after index discharge (C)

(A vs. B)

(B vs. C)

Drugs

 Blood pressure-lowering agents

4,544 (58.4%)

5,255 (67.6%)

5,819 (74.8%)

<0.0001

<0.0001

 Lipid-lowering agents

1,358 (17.5%)

1,446 (18.6%)

2,651 (34.1%)

0.0612

<0.0001

 Antiplatelet drugs

2,162 (27.8%)

2,754 (35.4%)

5,926 (76.2%)

<0.0001

<0.0001

 Oral anticoagulants

421 (5.4%)

499 (6.4%)

997 (12.8%)

0.0077

<0.0001

 Antiarrhythmics

345 (4.4%)

416 (5.3%)

535 (6.9%)

0.0082

<0.0001

 Antidiabetics

867 (11.1%)

1,233 (15.9%)

1,300 (16.7%)

0.0192

0.0002

 None of the previous

2,720 (35.0%)

1,958 (25.2%)

667 (8.6%)

<0.0001

<0.0001

Diagnostic procedures

 Cardiac doppler ultrasonography

690 (8.9%)

845 (10.9%)

1,075 (13.8%)

<0.0001

<0.0001

 Carotid doppler ultrasonography

633 (8.1%)

759 (9.8%)

1,172 (15.1%)

0.0004

<0.0001

 Neuroimaging or cerebral angiography

156 (2.0%)

277 (3.6%)

769 (9.9%)

<0.0001

<0.0001

 Electrocardiogram

1,739 (22.4%)

2,396 (30.8%)

2,525 (32.5%)

<0.0001

0.0119

 None of the previous

5,465 (70.3%)

4,744 (61.0%)

3,863 (49.7%)

<0.0001

<0.0001

Laboratory tests

 Total cholesterol

3,622 (46.6%)

3,827 (49.2%)

3,698 (47.6%)

0.0007

0.0149

 Glycosylated haemoglobin, Type A1C

1,070 (13.8%)

1,339 (17.2%)

1,434 (18.4%)

<0.0001

0.0024

 None of the previous

3,958 (50.9%)

3,720 (47.8%)

3,775 (48.5%)

<0.0001

0.1947

 None of the previous drugs, diagnostic procedures, nor laboratory tests

1,652 (21.2%)

1,104 (14.2%)

388 (5.0%)

<0.0001

<0.0001